Search
for
Sort by
Research 181–210 of 833
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- 46,XY DSD due to impaired androgen production
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Skin steroidogenesis in health and disease
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Idiopathic Hirsutism*
- 5α-Reduced glucocorticoids: a story of natural selection
- Thyroid hormone action on skin
- Mechanisms and cell lineages in lymphatic vascular development
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Reflections on how wound healing-promoting effects of the hair follicle can be translated into clinical practice
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- 5-Alpha reductase deficiency
- Familial and Sporadic Porphyria Cutanea Tarda
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Acquired scalp alopecia. Part II: A review
- The bright side of fibroblasts: molecular signature and regenerative cues in major organs
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review